Trademark: 88066824
Word
CLINICAL AND SAFETY EVALUATION (CASE RX)
Status
Registered
Status Code
700
Status Date
Tuesday, November 26, 2019
Serial Number
88066824
Registration Number
5922041
Registration Date
Tuesday, November 26, 2019
Mark Type
4000
Filing Date
Monday, August 6, 2018
Published for Opposition
Tuesday, March 5, 2019

Trademark Owner History

Classifications
36 Pharmacy benefit analysis services, namely, tracking, monitoring, assessing and analyzing information regarding prescription drug use and healthcare treatment, all to identify potential cost savings; drug utilization review services for pharmacy benefit management clients; pharmaceutical cost management services for pharmacy benefit management clients; reporting information in the field of pharmacy benefit management, pharmaceutical use and healthcare use, all to identify potential cost savings; safety management efforts, namely, tracking, monitoring, reporting, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, all to identify potential cost savings
44 Providing medical information, reporting and analysis in the fields of healthcare and pharmaceuticals and workers compensation; providing information in the field of healthcare as provided to pharmacy benefit management services clients, consultants and brokers, to improve clinical outcomes for injured workers; providing information in the field of healthcare treatment; care management, namely, tracking, monitoring, reporting, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, all for improved clinical outcomes
"CLINICAL AND SAFETY EVALUATION" AND "RX"

Trademark Events
Nov 26, 2019
Registered-Principal Register
Oct 22, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 21, 2019
Allowed Principal Register - Sou Accepted
Oct 21, 2019
Examiner's Amendment Entered
Oct 21, 2019
Notification Of Examiners Amendment E-Mailed
Oct 21, 2019
Examiners Amendment E-Mailed
Oct 21, 2019
Su-Examiner's Amendment Written
Oct 21, 2019
Statement Of Use Processing Complete
Sep 30, 2019
Use Amendment Filed
Oct 21, 2019
Case Assigned To Intent To Use Paralegal
Sep 30, 2019
Teas Statement Of Use Received
Jun 4, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 4, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 30, 2019
Noa E-Mailed - Sou Required From Applicant
Mar 5, 2019
Official Gazette Publication Confirmation E-Mailed
Mar 5, 2019
Published For Opposition
Feb 13, 2019
Notification Of Notice Of Publication E-Mailed
Jan 28, 2019
Approved For Pub - Principal Register
Jan 28, 2019
Examiner's Amendment Entered
Jan 28, 2019
Notification Of Examiners Amendment E-Mailed
Jan 28, 2019
Examiners Amendment E-Mailed
Jan 28, 2019
Examiners Amendment -Written
Jan 28, 2019
Previous Allowance Count Withdrawn
Jan 28, 2019
Withdrawn From Pub - Examining Attorney Request
Jan 24, 2019
Assigned To Lie
Jan 9, 2019
Approved For Pub - Principal Register
Jan 9, 2019
Examiner's Amendment Entered
Jan 9, 2019
Notification Of Examiners Amendment E-Mailed
Jan 9, 2019
Examiners Amendment E-Mailed
Jan 9, 2019
Examiners Amendment -Written
Dec 19, 2018
Teas/Email Correspondence Entered
Dec 18, 2018
Correspondence Received In Law Office
Dec 18, 2018
Teas Response To Office Action Received
Nov 16, 2018
Notification Of Non-Final Action E-Mailed
Nov 16, 2018
Non-Final Action E-Mailed
Nov 16, 2018
Non-Final Action Written
Nov 9, 2018
Assigned To Examiner
Aug 10, 2018
New Application Office Supplied Data Entered In Tram
Aug 9, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24